Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other Non-Current Liabilities (2016 - 2018)

OptimizeRx's Other Non-Current Liabilities history spans 9 years, with the latest figure at $1.3 million for Q2 2018.

  • On a quarterly basis, Other Non-Current Liabilities fell 43.93% to $1.3 million in Q2 2018 year-over-year; TTM through Jun 2018 was $1.3 million, a 43.93% decrease, with the full-year FY2017 number at $1.3 million, down 43.93% from a year prior.
  • Other Non-Current Liabilities hit $1.3 million in Q2 2018 for OptimizeRx, roughly flat from $1.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for OPRX hit a ceiling of $3.1 million in Q1 2014 and a floor of $1.3 million in Q4 2017.
  • Historically, Other Non-Current Liabilities has averaged $2.2 million across 5 years, with a median of $2.3 million in 2016.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 88.24% in 2014 and later grew 8.79% in 2015.
  • Tracing OPRX's Other Non-Current Liabilities over 5 years: stood at $2.2 million in 2014, then increased by 8.18% to $2.3 million in 2015, then dropped by 1.51% to $2.3 million in 2016, then plummeted by 43.93% to $1.3 million in 2017, then changed by 0.0% to $1.3 million in 2018.
  • Business Quant data shows Other Non-Current Liabilities for OPRX at $1.3 million in Q2 2018, $1.3 million in Q1 2018, and $1.3 million in Q4 2017.